ASCEnD Study
The study is funded by the NIHR Health Technology Assessment programme. The ASCEnD study tests whether aripiprazole plus sertraline is clinically effective and cost-effective compared with quetiapine monotherapy in adults with bipolar depr…
1 sources - 4 claims
The study is funded by the NIHR Health Technology Assessment programme. The ASCEnD study tests whether aripiprazole plus sertraline is clinically effective and cost-effective compared with quetiapine monotherapy in adults with bipolar depression.